These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 9603164)

  • 1. Timing and severity of initial hepatitis C recurrence as predictors of long-term liver allograft injury.
    Rosen HR; Gretch DR; Oehlke M; Flora KD; Benner KG; Rabkin JM; Corless CL
    Transplantation; 1998 May; 65(9):1178-82. PubMed ID: 9603164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
    Rosen HR; Shackleton CR; Higa L; Gralnek IM; Farmer DA; McDiarmid SV; Holt C; Lewin KJ; Busuttil RW; Martin P
    Am J Gastroenterol; 1997 Sep; 92(9):1453-7. PubMed ID: 9317061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor polymorphism of tumor necrosis factor gene: relationship with variable severity of hepatitis C recurrence after liver transplantation.
    Rosen HR; Lentz JJ; Rose SL; Rabkin J; Corless CL; Taylor K; Chou S
    Transplantation; 1999 Dec; 68(12):1898-902. PubMed ID: 10628771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomegalovirus viremia: risk factor for allograft cirrhosis after liver transplantation for hepatitis C.
    Rosen HR; Chou S; Corless CL; Gretch DR; Flora KD; Boudousquie A; Orloff SL; Rabkin JM; Benner KG
    Transplantation; 1997 Sep; 64(5):721-6. PubMed ID: 9311709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.
    Prieto M; Berenguer M; Rayón JM; Córdoba J; Argüello L; Carrasco D; García-Herola A; Olaso V; De Juan M; Gobernado M; Mir J; Berenguer J
    Hepatology; 1999 Jan; 29(1):250-6. PubMed ID: 9862874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are posttransplantation protocol liver biopsies useful in the long term?
    Berenguer M; Rayón JM; Prieto M; Aguilera V; Nicolás D; Ortiz V; Carrasco D; López-Andujar R; Mir J; Berenguer J
    Liver Transpl; 2001 Sep; 7(9):790-6. PubMed ID: 11552213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of histopathology in acute allograft rejection and recurrent hepatitis C infection after liver transplantation.
    Petrovic LM; Villamil FG; Vierling JM; Makowka L; Geller SA
    Liver Transpl Surg; 1997 Jul; 3(4):398-406. PubMed ID: 9346770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the recurrence of hepatitis C virus infection after liver transplantation on the long-term viability of the graft.
    Sánchez-Fueyo A; Restrepo JC; Quintó L; Bruguera M; Grande L; Sánchez-Tapias JM; Rodés J; Rimola A
    Transplantation; 2002 Jan; 73(1):56-63. PubMed ID: 11792978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus genotypes and quantification of serum hepatitis C RNA in liver transplant recipients. Relationship with histologic outcome of recurrent hepatitis C.
    Costes V; Durand L; Pageaux GP; Ducos J; Mondain AM; Picot MC; Domergue J; Larrey D; Baldet P
    Am J Clin Pathol; 1999 Feb; 111(2):252-8. PubMed ID: 9930149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of progressive hepatitis C recurrence after liver transplantation with combination interferon plus ribavirin.
    Gopal DV; Rabkin JM; Berk BS; Corless CL; Chou S; Olyaei A; Orloff SL; Rosen HR
    Liver Transpl; 2001 Mar; 7(3):181-90. PubMed ID: 11244158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of graft and patient survival in hepatitis C virus (HCV) recipients: model to predict HCV cirrhosis after liver transplantation.
    Iacob S; Cicinnati VR; Hilgard P; Iacob RA; Gheorghe LS; Popescu I; Frilling A; Malago M; Gerken G; Broelsch CE; Beckebaum S
    Transplantation; 2007 Jul; 84(1):56-63. PubMed ID: 17627238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Explanted liver inflammatory grade predicts fibrosis progression in hepatitis C recurrence.
    Ghabril M; Dickson RC; Krishna M; Machicao V; Aranda-Michel J; Bonatti H; Nguyen JH
    Liver Transpl; 2011 Jun; 17(6):685-94. PubMed ID: 21618689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of hepatitis C virus in liver allografts.
    Demetris AJ
    Liver Transpl; 2009 Nov; 15 Suppl 2():S35-41. PubMed ID: 19876940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholestatic hepatitis C in liver allografts.
    Taga SA; Washington MK; Terrault N; Wright TL; Somberg KA; Ferrell LD
    Liver Transpl Surg; 1998 Jul; 4(4):304-10. PubMed ID: 9649645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of hepatitis C infection after liver transplantation.
    Gane EJ; Portmann BC; Naoumov NV; Smith HM; Underhill JA; Donaldson PT; Maertens G; Williams R
    N Engl J Med; 1996 Mar; 334(13):815-20. PubMed ID: 8596547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of recurrent HCV infection after liver transplantation].
    Ostojić R
    Acta Med Croatica; 2005; 59(5):443-6. PubMed ID: 16381241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors that identify survival after liver retransplantation for allograft failure caused by recurrent hepatitis C infection.
    Neff GW; O'Brien CB; Nery J; Shire NJ; Nishida S; delaGarza J; Montalbano M; Safdar K; Ruiz P; Rideman E; Gascon JA; Tzakis AG; Madariaga J; Rudich SM
    Liver Transpl; 2004 Dec; 10(12):1497-503. PubMed ID: 15558835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative allograft histology after liver transplantation for cryptogenic cirrhosis, alcohol, hepatitis C, and cholestatic liver diseases.
    Maor-Kendler Y; Batts KP; Burgart LJ; Wiesner RH; Krom RA; Rosen CB; Charlton MR
    Transplantation; 2000 Jul; 70(2):292-7. PubMed ID: 10933151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of liver allograft fibrosis after transplantation for hepatitis C virus: persistent elevation of serum transaminase levels versus necroinflammatory activity.
    Pelletier SJ; Iezzoni JC; Crabtree TD; Hahn YS; Sawyer RG; Pruett TL
    Liver Transpl; 2000 Jan; 6(1):44-53. PubMed ID: 10648577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of different immunosuppression in the long-term histological outcome of HCV reinfection after liver transplantation for HCV cirrhosis.
    Papatheodoridis GV; Davies S; Dhillon AP; Teixeira R; Goulis J; Davidson B; Rolles K; Dusheiko G; Burroughs AK
    Transplantation; 2001 Aug; 72(3):412-8. PubMed ID: 11502968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.